查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1439440

數位/電動血壓計 - 全球市場考量、競爭狀況、市場預測 (2030)

Digital/Electrical Sphygmomanometer - Market Insights, Competitive Landscape, and Market Forecast - 2030
出版日期: 按訂單生產 | 出版商: DelveInsight | 英文 150 Pages | 商品交期: 2-10個工作天內

價格

全球數位/電子血壓計市場規模預計到2023年將達到9.7778億美元，到2030年將達到17.8388億美元，2024-2030年預測期間複合年增長率為10.57%。由於高血壓等血液相關疾病病例的增加、產品開發的快速發展和技術進步以及更容易患高血壓風險的老年人口的增加等因素，該市場呈現出積極的市場增長。

數位/電子血壓計市場動態

數位/電子血壓計市場的主要驅動因素之一是高血壓等血液相關疾病病例的增加。根據世界衛生組織（2022）的最新數據，目前全球約有12.8億30-79歲的成年人患有高血壓，其中大多數（三分之二）患者群體為中年。- 收入國家。已經確定，血壓升高與血液相關疾病和心血管疾病的診斷增加以及盛行率不斷升高有關。隨著時間的推移，這最終有助於數位/電子血壓計市場的成長。

此外，世界衛生組織 (WHO) 提供的數據顯示，心血管疾病 (CVD) 是全球死亡的主要原因，此類疾病每年奪走約 1,790 萬人的生命。

此外，根據European Society for Cardiology（ESC）的數據，心血管疾病（CVD）每年導致歐洲390萬人死亡，歐盟（EU）超過180萬人死亡。在歐洲，CVD 約佔所有死亡人數的 45%，在歐盟約佔 37%。因此，由於心血管疾病等血液相關疾病的盛行率不斷增加，預計數位/電子血壓計的需求將呈現高速增長，因此在預測期內（2024-2030）對數位/電子血壓計的需求將呈現高速成長。對市場成長有正面影響。

推動數位/電子血壓計市場成長的另一個主要因素是全球老年人口的增加。根據世界衛生組織（WHO）提供的數據，2020年，全球約有10億人年齡在60歲或以上。此外，到2050年，60歲及以上老年人口預計將增加一倍，達到約21億人，2020年至2050年，80歲及以上老年人口將增加兩倍，達到4.26億人。人口老化的增加預計將導致全球心血管疾病患者數量的增加，因為人口老化更容易患高血壓，最終導致心血管疾病和其他疾病的發展。預測期內（2024-2030）數字/電子血壓計的需求增加，推動數位/電子血壓計市場的成長。

除上述因素外，數位/電子血壓計領域的技術進步，例如開發新技術以提高產量和診斷準確性，預計也將推動數位/電子血壓計市場的成長。例如，2022年1月，Aktia宣佈與美國一家主要高血壓中心合作，其全球24小時血壓監測儀自動收集的數據比其他血壓監測儀多100倍，參與度高10倍，我們宣佈了一項具有里程碑意義的高血壓試驗在美國關於顯示器。

然而，某些因素，例如設備成本高、數位/電子血壓計過於敏感以至於身體運動影響準確性，或者某些設備僅在左臂上工作，這預計會抑制這種增長市場。此外，設備持續重新校準的需求可能是數位/電子血壓計市場成長的持續限制因素。

數位/電子血壓計市場細分分析

就數位/電子血壓計市場的產品類型細分而言，預計在預測期內（2024-2030年），便攜式數位/電子血壓計將佔據數位/電子血壓計市場的主要份額。這可能是由於與這些設備相關的某些功能所造成的。該產品領域的快速成長可歸因於對早期準確診斷的需求不斷增加，從而導致這些設備的廣泛採用。此外，全球醫院和家庭醫療保健領域越來越多地採用便攜式數位/電子血壓計也推動了市場的成長。

本報告提供了全球數位/電子血壓計市場的研究和分析，包括市場規模和預測、驅動因素和挑戰以及公司和產品概況。

目錄

第一章數字/電動血壓計市場報告簡介

第二章數字/電子血壓計市場執行摘要

  • 調查範圍
  • 市場概況
  • 競爭評估

第三章 監管分析

  • 美國
  • 歐洲
  • 日本
  • 中國

第四章數字/電動血壓計市場關鍵因素分析

  • 數位/電子血壓計市場的驅動因素
    • 高血壓等血液相關疾病增加
    • 產品開發的快速發展和技術進步
    • 老年人口患高血壓的風險增加
  • 數位/電子血壓計市場的限制與挑戰
    • 設備成本高
    • 需要不斷重新校準設備
  • 數位/電動血壓計的市場機會
    • 對家用設備的需求增加
    • 推出針對新興市場的產品

第五章數位/電子血壓計市場的波特五力分析

第六章 COVID-19對數位/電動血壓計市場的影響分析

第七章 數位/電動血壓計市場佈局

  • 按產品類型
    • 上臂
    • 手腕型
  • 按技術
    • 全自動
    • 半自動
  • 按可攜性
    • 便攜的
    • 非便攜式
  • 按最終用戶
    • 醫院、診所
    • 門診中心
    • 居家護理環境
    • 其他
  • 按地區
    • 北美
    • 歐洲
    • 亞太地區
    • 其他地區

第八章數位/電動血壓計市場：全球公司份額分析-主要3至5家公司

第九章數位/電動血壓計市場公司及產品概況

  • OMRON Healthcare, Inc.
  • Hill-Rom Services, Inc.
  • A&D Company Limited
  • SunTech Medical, Inc.
  • American Diagnostic Corporation
  • Withings
  • General Electric Company
  • Microlife Corporation
  • GF Health Products, Inc.
  • Spacelabs Healthcare
  • Rudolf Riester GmbH
  • Contec Medical Systems Co., Ltd.
  • ARCHOS (TM)
  • Panasonic Corporation
  • Yuwell-Jiangsu Yuyue medical equipment & supply Co., Ltd.
  • ERKA Kallmeyer Medizintechnik GmbH & Co. KG.
  • BOSCH + SOHN GmbH u. Co. KG.
  • Beijing Choice Electronic Tech Co., Ltd
  • Koninklijke Philips N.V.
  • SPENGLER HOLTEX Group

第10章 KOL觀點

第十一章專案方法

第 12 章. 關於 DelveInsight

第十三章 免責聲明與聯絡資訊

Product Code: DIMDCL0246

Digital/Electrical Sphygmomanometer Market By Product Type (Upper Arm, Wrist Type), By Technology (Full-Automatic, Semi-Automatic), By Portability (Portable, Non-Portable), By End-User (Hospitals And Clinics, Ambulatory Care Centers, Home Care Settings, Others), by geography is expected to grow at a steady CAGR forecast till 2030 owing to rising cases of blood-related disorders and rapid evolution of advanced devices

The Global Digital/Electrical Sphygmomanometer market was valued at USD 977.78 million in 2023, growing at a CAGR of 10.57%% during the forecast period from 2024 to 2030 to reach USD 1,783.88 million by 2030. The Digital/Electrical Sphygmomanometer market is witnessing a positive market growth owing to the factors such as the rising cases of blood-related disorders like high blood pressure and hypertension, rapid evolution and technological advancements in product development, increasing aging population who are more prone to hypertension risk.

Digital/Electrical Sphygmomanometer Market Dynamics:

One of the main drivers of the Digital/Electrical Sphygmomanometer market is the rising cases of blood-related disorders such as hypertension. As per the latest data provided by the WHO, 2022, approximately 1.28 billion adults in the 30-79 year age group are currently living with hypertension globally with the majority of the patient population (two-thirds) present in the low and middle-income countries. It has been established that increased blood pressure has been associated with the increased diagnosis which will lead to more and more prevalence of blood-related or cardiovascular diseases. This ultimately will contribute to the Digital/Electrical Sphygmomanometer market growth progression over time.

Moreover, as per the data provided by the World Health Organization, cardiovascular diseases (CVDs) are the leading cause of death across the globe, wherein this group of disease-account for an estimated 17.9 million lives each year.

Moreover, according to the data provided by the European Society for Cardiology (ESC), each year cardiovascular disease (CVD) causes 3.9 million deaths in Europe and over 1.8 million deaths in the European Union. They represent about 45% of all deaths in Europe and 37% in the EU. Therefore, the demand for Digital/Electrical Sphygmomanometer is set to witness an increased growth owing to the increasing prevalence of blood-related disorders like CVDs, thereby positively impacting the Digital/Electrical Sphygmomanometer market growth during the forecast period (2024-2030).

Another key factor responsible for the growth of the Digital/Electrical Sphygmomanometer market is the increasing geriatric population base across the globe. According to the data provided by the World Health Organization, in 2020, about one billion people across the world were over the age of 60. The source further stated that by 2050, the elderly population in the 60 and above age group is expected to double in number representing about 2.1 billion people, and people in the age group of 80 and above are estimated to triple between 2020 and 2050 to reach 426 million. The elderly population is more prone to developing high blood pressure which is ultimately associated with developing CVDs or other diseases, therefore, the rising elderly population is expected to lead to the rise in the patient population of cardiovascular diseases across the world, which in turn would lead to an increase in demand for Digital/Electrical Sphygmomanometer in the forecast period (2024-2030), which will drive the Digital/Electrical Sphygmomanometer market growth.

Along with the factors mentioned above, technological advancements in the field of Digital/Electrical Sphygmomanometer such as the development of new techniques to enhance the yield and diagnostic accuracy are also expected to aid in the growth of the Digital/Electrical Sphygmomanometer market. For instance, in January 2022, Aktiia announced a landmark hypertension trial in the United States in collaboration with a top US hypertension center, for its world's 24/7 blood pressure monitor, which automatically gathers over 100x the data and has over 10x the engagement of other blood pressure monitors.

However, certain factors like the high cost of devices and Digital/Electrical Sphygmomanometer being very sensitive due to which body movements affect its accuracy, or some devices only work on the left arm are expected to restrain the growth of this market. Moreover, the need for continuous recalibration of the devices may be certain limiting factors of the Digital/Electrical Sphygmomanometer market growth.

Moreover, the impact of the COVID-19 pandemic was positive on the Digital/Electrical Sphygmomanometer market. COVID-19 outbreak extensively instigated increased use of Digital/Electrical Sphygmomanometer as it was used as an essential procedure in events of complications to rule out issues associated with COVID-19. This resulted in the increased demand for Digital/Electrical Sphygmomanometer during the pandemic. Therefore, the market for Digital/Electrical Sphygmomanometer had a positive growth rate during the COVID-19 pandemic.

Digital/Electrical Sphygmomanometer Market Segment Analysis:

Digital/Electrical Sphygmomanometer Market By Product Type (Upper Arm, Wrist Type), By Technology (Full-Automatic, Semi-Automatic), By Portability (Portable, Non-Portable), By End-User (Hospitals and Clinics, Ambulatory Care Centers, Home Care Settings, Others), and By Geography (North America, Europe, Asia-Pacific, And Rest of the World)

In the Product Type segment of the Digital/Electrical Sphygmomanometer market, the Portable Digital/Electrical Sphygmomanometer is estimated to hold a significant share in the Digital/Electrical Sphygmomanometer market during the forecast period (2024-2030). This can be attributed to the specific features associated with these devices. The rapid growth of this product segment can be attributed to the growing demand for early and accurate diagnosis and leads to the high adoption of these devices. Further, the growing adoption of Portable Digital/Electrical Sphygmomanometer by hospitals and the in-home healthcare sector around the world is also driving the market growth.

Since the beginning of the COVID-19 pandemic, the demand for portable Digital/Electrical Sphygmomanometer has been on the rise. Portable Digital/Electrical Sphygmomanometer provides high-quality tracings that can be achieved both at home and in the office setting. Also, Portable Digital/Electrical Sphygmomanometer are an important contribution to epidemiologic and clinical studies that require frequent measures of a more broad range of cardiology function parameters. Therefore, the growing demand for disease diagnosis and treatment benefits the segment growth of the Digital/Electrical Sphygmomanometer market. Hence, their reliability has constantly increased with time and advancements in the newer generation of devices. Therefore, considering the advantages associated with Portable Digital/Electrical Sphygmomanometer, this category is expected to generate significant revenue share eventually contributing to the overall growth of the global Digital/Electrical Sphygmomanometer market during the forecast period.

North America is expected to dominate the overall Digital/Electrical Sphygmomanometer Market:

Among all the regions, North America is expected to account for the largest share in the global Digital/Electrical Sphygmomanometer market. Factors such as the high risk of blood pressure and hypertension among the population, technological advancement in product development, and increased product launches are expected to aid in the growth of the North America Digital/Electrical Sphygmomanometer Market in this region.

As per the data provided by the Centers for Disease Control and Prevention, as of 2022, High blood pressure, high blood cholesterol, and smoking are key risk factors for heart disease. About half of people in the United States (47%) have at least one of these three risk factors.

Additionally, according to the data of the American Heart Association 2022, in the year 2018, Coronary Heart Disease (CHD) was the leading cause (42.1%) of deaths in the US, attributable to high blood pressure (11.0%), Heart failure (9.6%), diseases of the arteries (2.9%), and others (17.4%).

Therefore, the rising risk factors of blood-related disorders in the country would result in the rising demand for treatments that make use of Digital/Electrical Sphygmomanometer, which in turn would provide a conducive growth environment for the United States Digital/Electrical Sphygmomanometer market as well as the North American region.

Furthermore, the increased emphasis on product development activities and high interest of device manufacturers in accessing local markets further aid in the growth of the regional markets for Digital/Electrical Sphygmomanometer. For instance, in march 2022, Qardio, Inc. announced the US Food and Drug Administration (FDA) 510k clearance for its QardioCore ambulatory ECG device. QardioCore extended Qardio's remote patient monitoring platform from primary care and hypertension monitoring to acute care and cardiology, in a single, intuitive platform.

The product launches in the local markets correlate to a significant reduction in costs thereby making them affordable for end-users which in turn drives the product demand in the market. Therefore, the interplay of various factors such as the presence of a large patient population, as well as new product launches in the region is expected to boost the North America Digital/Electrical Sphygmomanometer market during the forecast period.

Digital/Electrical Sphygmomanometer Market Key Players:

Some of the key market players operating in the Digital/Electrical Sphygmomanometer market include OMRON Healthcare, Inc., Hill-Rom Services, Inc., A&D Company Limited, SunTech Medical, Inc., American Diagnostic Corporation, Withings, General Electric Company, Microlife Corporation, GF Health Products, Inc., Spacelabs Healthcare, Rudolf Riester GmbH, Contec Medical Systems Co., Ltd., ARCHOS(TM), Panasonic Corporation, Yuwell-Jiangsu Yuyue medical equipment & supply Co., Ltd., ERKA Kallmeyer Medizintechnik GmbH & Co. KG., BOSCH + SOHN GmbH u. Co. KG., Beijing Choice Electronic Tech Co., Ltd, Koninklijke Philips N.V., SPENGLER HOLTEX Group and others.

Recent Developmental Activities in the Digital/Electrical Sphygmomanometer Market:

In February 2022, Abbott announced the US Food and Drug Administration (FDA) approval of an expanded indication for its CardioMEMS(TM) HF System to support the care of more people living with heart failure. The sensor provides an early warning system enabling doctors to protect against worsening heart failure.

In November 2020, Blipcare developed a Wi-Fi blood pressure monitor and announced the availability of its new cellular blood pressure monitor, the Blip BP 800.

Key Takeaways from the Digital/Electrical Sphygmomanometer Market Report Study

  • Market size analysis for current Digital/Electrical Sphygmomanometer market size (2023), and market forecast for 5 years (2024-2030)
  • The effect of the COVID-19 pandemic on this market is significant. To capture and analyze suitable indicators, our experts are closely watching the Digital/Electrical Sphygmomanometer market.
  • Top key product/services/technology developments, merger, acquisition, partnership, joint venture happened for last 3 years
  • Key companies dominating the global Digital/Electrical Sphygmomanometer market.
  • Various opportunities available for the other competitor in the Digital/Electrical Sphygmomanometer market space.
  • What are the top performing segments in 2023? How these segments will perform in 2030.
  • Which is the top-performing regions and countries in the current Digital/Electrical Sphygmomanometer market scenario?
  • Which are the regions and countries where companies should have concentrated on opportunities for Digital/Electrical Sphygmomanometer market growth in the coming future?

Target Audience who can be benefited from this Digital/Electrical Sphygmomanometer Market Report Study

  • Digital/Electrical Sphygmomanometer products providers
  • Research organizations and consulting companies
  • Digital/Electrical Sphygmomanometer-related organizations, associations, forums, and other alliances
  • Government and corporate offices
  • Start-up companies, venture capitalists, and private equity firms
  • Distributors and Traders dealing in Digital/Electrical Sphygmomanometer
  • Various End-users who want to know more about the Digital/Electrical Sphygmomanometer market and latest technological developments in the Digital/Electrical Sphygmomanometer market.

Frequently Asked Questions for Digital/Electrical Sphygmomanometer Market:

1. What is a Digital/Electrical Sphygmomanometer?

Sphygmomanometers are medical devices that are used to measure blood pressure (mainly in arteries). These devices are of three types mainly mercury sphygmomanometers, an aneroid sphygmomanometer, and electronic/digital sphygmomanometer. A digital sphygmomanometer works on an oscillometric principle in which the blood pressure in an artery is measured by sensing arterial wall vibrations.

2. What is the market for Global Digital/Electrical Sphygmomanometer?

The Global Digital/Electrical Sphygmomanometer market was valued at USD 977.78 million in 2023, growing at a CAGR of 10.57%% during the forecast period from 2024 to 2030 to reach USD 1,783.88 million by 2030.

3. What are the drivers for the Global Digital/Electrical Sphygmomanometer Market?

The Digital/Electrical Sphygmomanometer market is witnessing a positive market growth owing to the factors such as the rising cases of blood-related disorders like high blood pressure and hypertension, rapid evolution and technological advancements in product development, increasing aging population who are more prone to hypertension risk.

4. Who are the key players operating in the Global Digital/Electrical Sphygmomanometer Market?

Some of the key market players operating in the Digital/Electrical Sphygmomanometer market include OMRON Healthcare, Inc., Hill-Rom Services, Inc., A&D Company Limited, SunTech Medical, Inc., American Diagnostic Corporation, Withings, General Electric Company, Microlife Corporation, GF Health Products, Inc., Spacelabs Healthcare, Rudolf Riester GmbH, Contec Medical Systems Co., Ltd., ARCHOS(TM), Panasonic Corporation, Yuwell-Jiangsu Yuyue medical equipment & supply Co., Ltd., ERKA Kallmeyer Medizintechnik GmbH & Co. KG., BOSCH + SOHN GmbH u. Co. KG., Beijing Choice Electronic Tech Co., Ltd, Koninklijke Philips N.V., SPENGLER HOLTEX Group and others.

5. Which region has the highest share in Digital/Electrical Sphygmomanometer Market?

North America is expected to hold the highest share in the revenue in the Digital/Electrical Sphygmomanometer market during the forecast period. Factors such as the high risk of blood pressure and hypertension among the population, technological advancement in product development, and increased product launches are also expected to aid in the Digital/Electrical Sphygmomanometer market growth in this region.

Table of Contents

1.Digital/Electrical Sphygmomanometer Market Report Introduction

2.Digital/Electrical Sphygmomanometer Market Executive Summary

  • 2.1. Scope of the Study
  • 2.2. Market at Glance
  • 2.3. Competitive Assessment

3. Regulatory Analysis

  • 3.1. The United States
  • 3.2. Europe
  • 3.3. Japan
  • 3.4. China

4. Digital/Electrical Sphygmomanometer Market Key Factors Analysis

  • 4.1. Digital/Electrical Sphygmomanometer Market Drivers
    • 4.1.1. The Rising Cases of Blood-Related Disorders like High Blood Pressure and Hypertension
    • 4.1.2. Rapid Evolution and Technological Advancements in Product Development
    • 4.1.3. Increasing Aging Population prone to Hypertension Risk
  • 4.2. Digital/Electrical Sphygmomanometer Market Restraints and Challenges
    • 4.2.1. The High Cost of Devices
    • 4.2.2. Need for Continuous Recalibration of the Devices
  • 4.3. Digital/Electrical Sphygmomanometer Market Opportunities
    • 4.3.1. Increasing Demand for Home-Based Devices
    • 4.3.2. Targeting Emerging Markets for Product Launches

5. Digital/Electrical Sphygmomanometer Market Porter's Five Forces Analysis

  • 5.1. Bargaining Power of Suppliers
  • 5.2. Bargaining Power of Consumers
  • 5.3. Threat of New Entrants
  • 5.4. Threat of Substitutes
  • 5.5. Competitive Rivalry

6. COVID-19 Impact Analysis on Digital/Electrical Sphygmomanometer Market

7. Digital/Electrical Sphygmomanometer Market Layout

  • 7.1. By Product Type
    • 7.1.1. Upper Arm
    • 7.1.2. Wrist Type
  • 7.2. By Technology
    • 7.2.1. Full-Automatic
    • 7.2.2. Semi-Automatic
  • 7.3. By Portability
    • 7.3.1. Portable
    • 7.3.2. Non-Portable
  • 7.4. By End User
    • 7.4.1. Hospitals and Clinics
    • 7.4.2. Ambulatory Care Centers
    • 7.4.3. Home Care Settings
    • 7.4.4. Others
  • 7.5. By Geography
    • 7.5.1. North America
      • 7.5.1.1. United States
      • 7.5.1.2. Canada
      • 7.5.1.3. Mexico
    • 7.5.2. Europe
      • 7.5.2.1. France
      • 7.5.2.2. Germany
      • 7.5.2.3. United Kingdom
      • 7.5.2.4. Italy
      • 7.5.2.5. Spain
      • 7.5.2.6. Russia
      • 7.5.2.7. Rest of Europe
    • 7.5.3. Asia-Pacific
      • 7.5.3.1. China
      • 7.5.3.2. Japan
      • 7.5.3.3. India
      • 7.5.3.4. Australia
      • 7.5.3.5. South Korea
      • 7.5.3.6. Rest of Asia Pacific
    • 7.5.4. Rest of the World (RoW)
      • 7.5.4.1. Middle East
      • 7.5.4.2. Africa
      • 7.5.4.3. South America

8. Digital/Electrical Sphygmomanometer Market Global Company Share Analysis - Key 3-5 Companies

9. Digital/Electrical Sphygmomanometer Market Company and Product Profiles

  • 9.1. OMRON Healthcare, Inc.
    • 9.1.1. Company Overview
    • 9.1.2. Company Snapshot
    • 9.1.3. Financial Overview
    • 9.1.4. Product Listing
    • 9.1.5. Entropy
  • 9.2. Hill-Rom Services, Inc.
    • 9.2.1. Company Overview
    • 9.2.2. Company Snapshot
    • 9.2.3. Financial Overview
    • 9.2.4. Product Listing
    • 9.2.5. Entropy
  • 9.3. A&D Company Limited
    • 9.3.1. Company Overview
    • 9.3.2. Company Snapshot
    • 9.3.3. Financial Overview
    • 9.3.4. Product Listing
    • 9.3.5. Entropy
  • 9.4. SunTech Medical, Inc.
    • 9.4.1. Company Overview
    • 9.4.2. Company Snapshot
    • 9.4.3. Financial Overview
    • 9.4.4. Product Listing
    • 9.4.5. Entropy
  • 9.5. American Diagnostic Corporation
    • 9.5.1. Company Overview
    • 9.5.2. Company Snapshot
    • 9.5.3. Financial Overview
    • 9.5.4. Product Listing
    • 9.5.5. Entropy
  • 9.6. Withings
    • 9.6.1. Company Overview
    • 9.6.2. Company Snapshot
    • 9.6.3. Financial Overview
    • 9.6.4. Product Listing
    • 9.6.5. Entropy
  • 9.7. General Electric Company
    • 9.7.1. Company Overview
    • 9.7.2. Company Snapshot
    • 9.7.3. Financial Overview
    • 9.7.4. Product Listing
    • 9.7.5. Entropy
  • 9.8. Microlife Corporation
    • 9.8.1. Company Overview
    • 9.8.2. Company Snapshot
    • 9.8.3. Financial Overview
    • 9.8.4. Product Listing
    • 9.8.5. Entropy
  • 9.9. GF Health Products, Inc.
    • 9.9.1. Company Overview
    • 9.9.2. Company Snapshot
    • 9.9.3. Financial Overview
    • 9.9.4. Product Listing
    • 9.9.5. Entropy
  • 9.10. Spacelabs Healthcare
    • 9.10.1. Company Overview
    • 9.10.2. Company Snapshot
    • 9.10.3. Financial Overview
    • 9.10.4. Product Listing
    • 9.10.5. Entropy
  • 9.11. Rudolf Riester GmbH
    • 9.11.1. Company Overview
    • 9.11.2. Company Snapshot
    • 9.11.3. Financial Overview
    • 9.11.4. Product Listing
    • 9.11.5. Entropy
  • 9.12. Contec Medical Systems Co., Ltd.
    • 9.12.1. Company Overview
    • 9.12.2. Company Snapshot
    • 9.12.3. Financial Overview
    • 9.12.4. Product Listing
    • 9.12.5. Entropy
  • 9.13. ARCHOS(TM)
    • 9.13.1. Company Overview
    • 9.13.2. Company Snapshot
    • 9.13.3. Financial Overview
    • 9.13.4. Product Listing
    • 9.13.5. Entropy
  • 9.14. Panasonic Corporation
    • 9.14.1. Company Overview
    • 9.14.2. Company Snapshot
    • 9.14.3. Financial Overview
    • 9.14.4. Product Listing
    • 9.14.5. Entropy
  • 9.15. Yuwell-Jiangsu Yuyue medical equipment & supply Co., Ltd.
    • 9.15.1. Company Overview
    • 9.15.2. Company Snapshot
    • 9.15.3. Financial Overview
    • 9.15.4. Product Listing
  • 9.16. ERKA Kallmeyer Medizintechnik GmbH & Co. KG.
    • 9.16.1. Company Overview
    • 9.16.2. Company Snapshot
    • 9.16.3. Financial Overview
    • 9.16.4. Product Listing
    • 9.16.5. Entropy
  • 9.17. BOSCH + SOHN GmbH u. Co. KG.
    • 9.17.1. Company Overview
    • 9.17.2. Company Snapshot
    • 9.17.3. Financial Overview
    • 9.17.4. Product Listing
    • 9.17.5. Entropy
  • 9.18. Beijing Choice Electronic Tech Co., Ltd
    • 9.18.1. Company Overview
    • 9.18.2. Company Snapshot
    • 9.18.3. Financial Overview
    • 9.18.4. Product Listing
    • 9.18.5. Entropy
  • 9.19. Koninklijke Philips N.V.
    • 9.19.1. Company Overview
    • 9.19.2. Company Snapshot
    • 9.19.3. Financial Overview
    • 9.19.4. Product Listing
    • 9.19.5. Entropy
  • 9.20. SPENGLER HOLTEX Group
    • 9.20.1. Company Overview
    • 9.20.2. Company Snapshot
    • 9.20.3. Financial Overview
    • 9.20.4. Product Listing
    • 9.20.5. Entropy

10. KOL Views

11. PROJECT APPROACH

12. About DelveInsight

13. Disclaimer & Contact Us

List of Tables

  • Table 1: Competitive Analysis
  • Table 2: COVID-19 Impact Analysis
  • Table 3: Digital/Electrical Sphygmomanometer Market in Global (2021-2030)
  • Table 4: Digital/Electrical Sphygmomanometer Market in Global by Product Type (2021-2030)
  • Table 5: Digital/Electrical Sphygmomanometer Market in Global by Technology (2021-2030)
  • Table 6: Digital/Electrical Sphygmomanometer Market in Global by Portability (2021-2030)
  • Table 7: Digital/Electrical Sphygmomanometer Market in Global by End User (2021-2030)
  • Table 8: Digital/Electrical Sphygmomanometer Market in Global by Geography (2021-2030)
  • Table 9: Digital/Electrical Sphygmomanometer Market in North America (2021-2030)
  • Table 10: Digital/Electrical Sphygmomanometer Market in North America by Country (2021-2030)
  • Table 11: Digital/Electrical Sphygmomanometer Market in the US (2021-2030)
  • Table 12: Digital/Electrical Sphygmomanometer Market in Canada (2021-2030)
  • Table 13: Digital/Electrical Sphygmomanometer Market in Mexico (2021-2030)
  • Table 14: Digital/Electrical Sphygmomanometer Market in Europe (2021-2030)
  • Table 15: Digital/Electrical Sphygmomanometer Market in Europe by Country (2021-2030)
  • Table 16: Digital/Electrical Sphygmomanometer Market in France (2021-2030)
  • Table 17: Digital/Electrical Sphygmomanometer Market in Germany (2021-2030)
  • Table 18: Digital/Electrical Sphygmomanometer Market in the United Kingdom (2021-2030)
  • Table 19: Digital/Electrical Sphygmomanometer Market in Italy (2021-2030)
  • Table 20: Digital/Electrical Sphygmomanometer Market in Spain (2021-2030)
  • Table 21: Digital/Electrical Sphygmomanometer Market in Russia (2021-2030)
  • Table 22: Digital/Electrical Sphygmomanometer Market in Rest of Europe (2021-2030)
  • Table 23: Digital/Electrical Sphygmomanometer Market in APAC (2021-2030)
  • Table 24: Digital/Electrical Sphygmomanometer Market in APAC by Country (2021-2030)
  • Table 25: Digital/Electrical Sphygmomanometer Market in China (2021-2030)
  • Table 26: Digital/Electrical Sphygmomanometer Market in Japan (2021-2030)
  • Table 27: Digital/Electrical Sphygmomanometer Market in India (2021-2030)
  • Table 28: Digital/Electrical Sphygmomanometer Market in Australia (2021-2030)
  • Table 29: Digital/Electrical Sphygmomanometer Market in South Korea (2021-2030)
  • Table 30: Digital/Electrical Sphygmomanometer Market in Rest of APAC (2021-2030)
  • Table 31: Digital/Electrical Sphygmomanometer Market in Rest of World (2021-2030)
  • Table 32: Digital/Electrical Sphygmomanometer Market in RoW by Region (2021-2030)
  • Table 33: Digital/Electrical Sphygmomanometer Market in Middle East (2021-2030)
  • Table 34: Digital/Electrical Sphygmomanometer Market in Africa (2021-2030)
  • Table 35: Digital/Electrical Sphygmomanometer Market in South America (2021-2030)

List of Figures

  • Figure 1: Competitive Analysis
  • Figure 2: COVID-19 Impact Analysis
  • Figure 3: Digital/Electrical Sphygmomanometer Market in Global (2021-2030)
  • Figure 4: Digital/Electrical Sphygmomanometer Market in Global by Product Type (2021-2030)
  • Figure 5: Digital/Electrical Sphygmomanometer Market in Global by Technology (2021-2030)
  • Figure 6: Digital/Electrical Sphygmomanometer Market in Global by Portability (2021-2030)
  • Figure 7: Digital/Electrical Sphygmomanometer Market in Global by End User (2021-2030)
  • Figure 8: Digital/Electrical Sphygmomanometer Market in Global by Geography (2021-2030)
  • Figure 9: Digital/Electrical Sphygmomanometer Market in North America (2021-2030)
  • Figure 10: Digital/Electrical Sphygmomanometer Market in North America by Country (2021-2030)
  • Figure 11: Digital/Electrical Sphygmomanometer Market in the US (2021-2030)
  • Figure 12: Digital/Electrical Sphygmomanometer Market in Canada (2021-2030)
  • Figure 13: Digital/Electrical Sphygmomanometer Market in Mexico (2021-2030)
  • Figure 14: Digital/Electrical Sphygmomanometer Market in Europe (2021-2030)
  • Figure 15: Digital/Electrical Sphygmomanometer Market in Europe by Country (2021-2030)
  • Figure 16: Digital/Electrical Sphygmomanometer Market in France (2021-2030)
  • Figure 17: Digital/Electrical Sphygmomanometer Market in Germany (2021-2030)
  • Figure 18: Digital/Electrical Sphygmomanometer Market in the United Kingdom (2021-2030)
  • Figure 19: Digital/Electrical Sphygmomanometer Market in Italy (2021-2030)
  • Figure 20: Digital/Electrical Sphygmomanometer Market in Spain (2021-2030)
  • Figure 21: Digital/Electrical Sphygmomanometer Market in Russia (2021-2030)
  • Figure 22: Digital/Electrical Sphygmomanometer Market in Rest of Europe (2021-2030)
  • Figure 23: Digital/Electrical Sphygmomanometer Market in APAC (2021-2030)
  • Figure 24: Digital/Electrical Sphygmomanometer Market in APAC by Country (2021-2030)
  • Figure 25: Digital/Electrical Sphygmomanometer Market in China (2021-2030)
  • Figure 26: Digital/Electrical Sphygmomanometer Market in Japan (2021-2030)
  • Figure 27: Digital/Electrical Sphygmomanometer Market in India (2021-2030)
  • Figure 28: Digital/Electrical Sphygmomanometer Market in Australia (2021-2030)
  • Figure 29: Digital/Electrical Sphygmomanometer Market in South Korea (2021-2030)
  • Figure 30: Digital/Electrical Sphygmomanometer Market in Rest of APAC (2021-2030)
  • Figure 31: Digital/Electrical Sphygmomanometer Market in Rest of World (2021-2030)
  • Figure 32: Digital/Electrical Sphygmomanometer Market in RoW by Region (2021-2030)
  • Figure 33: Digital/Electrical Sphygmomanometer Market in Middle East (2021-2030)
  • Figure 34: Digital/Electrical Sphygmomanometer Market in Africa (2021-2030)
  • Figure 35: Digital/Electrical Sphygmomanometer Market in South America (2021-2030)
  • Figure 36: Market Drivers
  • Figure 37: Market Barriers
  • Figure 38: Marker Opportunities
  • Figure 39: PORTER'S Five Force Analysis